# ABVC BioPharma Inc. (ABVC)

Source: https://www.quantisnow.com/company/ABVC
Generated: 2026-10-28T11:30:24.706Z

- Ticker: ABVC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001173313
- Website: abvcpharma.com

## About

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.

## Latest ABVC news and filings

- 2026-09-29 16:22 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-abvc-biopharma-inc-6728956)
- 2026-09-11 20:30 UTC [SEC Form PRER14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-abvc-biopharma-inc-6713123)
- 2026-08-27 12:30 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-entry-into-a-6696540)
- 2026-08-25 20:30 UTC [SEC Form PRER14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-abvc-biopharma-inc-6694420)
- 2026-08-17 20:19 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6685068)
- 2026-08-17 20:18 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6685059)
- 2026-08-17 20:17 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6685058)
- 2026-08-17 20:16 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6685047)
- 2026-08-12 21:00 UTC [SEC Form PRER14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-prer14a-filed-by-abvc-biopharma-inc-6678472)
- 2026-08-12 20:06 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-abvc-biopharma-inc-6677843)
- 2026-08-12 15:50 UTC [SEC Form 8-K] [Amendment: ABVC BioPharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/amendment-abvc-biopharma-inc-filed-sec-form-8-k-other-events-6677418)
- 2026-08-04 01:12 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-other-events-6660724)
- 2026-07-28 20:31 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-abvc-biopharma-inc-6651737)
- 2026-07-02 20:01 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-changes-in-registrants-6625006)
- 2026-05-18 11:22 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-abvc-biopharma-inc-6559077)
- 2026-05-15 21:00 UTC [SEC Form NT 10-Q filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-abvc-biopharma-inc-6558241)
- 2026-03-27 20:30 UTC [SEC Form POS AM filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-abvc-biopharma-inc-6474912)
- 2026-03-27 20:05 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-submission-of-matters-6474586)
- 2026-03-05 21:29 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-abvc-biopharma-inc-6432730)
- 2026-03-03 21:19 UTC [SEC Form 10-Q] [Amendment: SEC Form 10-Q/A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-qa-filed-by-abvc-biopharma-inc-6425458)
- 2026-03-03 21:20 UTC [SEC Form 10-K] [SEC Form 10-K filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-abvc-biopharma-inc-6425425)
- 2026-03-03 21:14 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-results-of-operations-6425357)
- 2026-02-05 22:29 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-abvc-biopharma-inc-6378537)
- 2026-01-16 21:30 UTC [SEC Form 8-K] [Amendment: ABVC BioPharma Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-abvc-biopharma-inc-filed-sec-form-8-k-unregistered-sales-6352292)
- 2025-11-14 21:29 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6280889)
- 2025-11-14 21:28 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6280879)
- 2025-11-14 21:28 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6280840)
- 2025-11-14 21:27 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6280835)
- 2025-11-03 12:30 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-results-of-operations-6255454)
- 2025-10-31 23:39 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-abvc-biopharma-inc-6255169)
- 2025-10-30 12:31 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-leadership-update-financial-6251608)
- 2025-08-15 20:24 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6168491)
- 2025-08-15 20:23 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6168483)
- 2025-08-15 20:21 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6168478)
- 2025-08-15 20:19 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6168466)
- 2025-08-15 20:18 UTC [SEC Form 424B4 filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-424b4-filed-by-abvc-biopharma-inc-6168458)
- 2025-08-14 11:02 UTC [SEC Form 8-K] [ABVC BioPharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/abvc-biopharma-inc-filed-sec-form-8-k-results-of-operations-6164366)
- 2025-08-13 20:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-abvc-biopharma-inc-6162876)
- 2025-07-18 21:04 UTC [SEC Form 8-K] [Amendment: ABVC BioPharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-abvc-biopharma-inc-filed-sec-form-8-k-entry-into-6125744)
- 2025-07-15 20:30 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by ABVC BioPharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-abvc-biopharma-inc-6120863)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ABVC
- RSS and alerts for ABVC: https://www.quantisnow.com/docs/rss-feeds.md